Mangoceuticals, Inc. (MGRX) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
7/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseMGRX / S&P 5.56% / 15.20% |
LoseMGRX / S&P -38.91% / 15.00% |
LoseMGRX / S&P -69.85% / 50.40% |
| 2026-Q10/3 |
LoseMGRX / S&P -51.35% / -4.33% |
LoseMGRX / S&P -18.88% / 11.30% |
LoseMGRX / S&P -64.10% / 27.70% |
| 2025-Q40/3 |
LoseMGRX / S&P -66.21% / 2.65% |
LoseMGRX / S&P -25.96% / 9.00% |
LoseMGRX / S&P -47.24% / 13.40% |
| 2025-Q31/3 |
WinMGRX / S&P 44.08% / 8.12% |
LoseMGRX / S&P -38.16% / 4.61% |
LoseMGRX / S&P -50.93% / 13.45% |
| 2025-Q20/3 |
LoseMGRX / S&P -22.05% / 10.94% |
LoseMGRX / S&P -40.47% / 4.83% |
LoseMGRX / S&P -48.22% / 10.63% |
| 2025-Q10/3 |
LoseMGRX / S&P -19.42% / -4.27% |
LoseMGRX / S&P -39.51% / 4.98% |
LoseMGRX / S&P -20.80% / 10.57% |
| 2024-Q41/3 |
LoseMGRX / S&P -31.64% / 2.41% |
LoseMGRX / S&P -15.81% / 5.25% |
WinMGRX / S&P 14.11% / 6.15% |
| 2024-Q31/3 |
LoseMGRX / S&P -22.37% / 5.89% |
LoseMGRX / S&P MGRX unavailable / 5.89% |
WinMGRX / S&P 177.46% / 6.11% |
| 2024-Q22/3 |
WinMGRX / S&P 40.09% / 4.28% |
LoseMGRX / S&P MGRX unavailable / 5.38% |
WinMGRX / S&P 1120.75% / 5.12% |
| 2024-Q11/3 |
LoseMGRX / S&P -21.66% / 10.56% |
LoseMGRX / S&P MGRX unavailable / 5.71% |
WinMGRX / S&P 1118.60% / 5.59% |
| 2023-Q40/3 |
LoseMGRX / S&P -67.45% / 11.69% |
LoseMGRX / S&P MGRX unavailable / 6.81% |
LoseMGRX / S&P MGRX unavailable / 7.78% |
| 2023-Q30/3 |
LoseMGRX / S&P -53.50% / -3.27% |
LoseMGRX / S&P MGRX unavailable / 7.52% |
LoseMGRX / S&P MGRX unavailable / -5.03% |
| 2023-Q21/3 |
WinMGRX / S&P 60.53% / 8.74% |
LoseMGRX / S&P MGRX unavailable / 9.50% |
LoseMGRX / S&P MGRX unavailable / -8.57% |
| 2023-Q10/3 |
LoseMGRX / S&P MGRX unavailable / 7.50% |
LoseMGRX / S&P MGRX unavailable / 10.77% |
LoseMGRX / S&P MGRX unavailable / -15.69% |
| 2022-Q40/3 |
LoseMGRX / S&P MGRX unavailable / 7.56% |
LoseMGRX / S&P MGRX unavailable / 11.88% |
LoseMGRX / S&P MGRX unavailable / -17.99% |
| 2022-Q30/3 |
LoseMGRX / S&P MGRX unavailable / -4.88% |
LoseMGRX / S&P MGRX unavailable / 13.47% |
LoseMGRX / S&P MGRX unavailable / -1.41% |
| 2022-Q20/3 |
LoseMGRX / S&P MGRX unavailable / -16.10% |
LoseMGRX / S&P MGRX unavailable / 13.71% |
LoseMGRX / S&P MGRX unavailable / 11.04% |
| 2022-Q10/3 |
LoseMGRX / S&P MGRX unavailable / -4.60% |
LoseMGRX / S&P MGRX unavailable / 15.97% |
LoseMGRX / S&P MGRX unavailable / 42.23% |
| 2021-Q40/3 |
LoseMGRX / S&P MGRX unavailable / 11.03% |
LoseMGRX / S&P MGRX unavailable / 15.00% |
LoseMGRX / S&P MGRX unavailable / 96.40% |
| 2021-Q30/3 |
LoseMGRX / S&P MGRX unavailable / 0.58% |
LoseMGRX / S&P MGRX unavailable / 10.77% |
LoseMGRX / S&P MGRX unavailable / 69.42% |
| 2021-Q20/3 |
LoseMGRX / S&P MGRX unavailable / 8.55% |
LoseMGRX / S&P MGRX unavailable / 6.58% |
LoseMGRX / S&P MGRX unavailable / 51.81% |
| 2021-Q10/3 |
LoseMGRX / S&P MGRX unavailable / 6.17% |
LoseMGRX / S&P MGRX unavailable / -1.06% |
LoseMGRX / S&P MGRX unavailable / 7.39% |
| 2020-Q40/3 |
LoseMGRX / S&P MGRX unavailable / 12.15% |
LoseMGRX / S&P MGRX unavailable / -3.72% |
LoseMGRX / S&P MGRX unavailable / -33.42% |
| 2020-Q30/3 |
LoseMGRX / S&P MGRX unavailable / 8.93% |
LoseMGRX / S&P MGRX unavailable / -2.04% |
LoseMGRX / S&P MGRX unavailable / -27.10% |
| 2020-Q20/3 |
LoseMGRX / S&P MGRX unavailable / 20.54% |
LoseMGRX / S&P MGRX unavailable / -0.46% |
LoseMGRX / S&P MGRX unavailable / -27.11% |
| 2020-Q10/3 |
LoseMGRX / S&P MGRX unavailable / -19.60% |
LoseMGRX / S&P MGRX unavailable / 3.47% |
LoseMGRX / S&P MGRX unavailable / -14.75% |
| 2019-Q40/3 |
LoseMGRX / S&P MGRX unavailable / 9.07% |
LoseMGRX / S&P MGRX unavailable / 5.36% |
LoseMGRX / S&P MGRX unavailable / 2.99% |
| 2019-Q30/3 |
LoseMGRX / S&P MGRX unavailable / 1.70% |
LoseMGRX / S&P MGRX unavailable / 5.02% |
LoseMGRX / S&P MGRX unavailable / 0.21% |
| 2019-Q20/3 |
LoseMGRX / S&P MGRX unavailable / 4.30% |
LoseMGRX / S&P MGRX unavailable / 6.64% |
LoseMGRX / S&P MGRX unavailable / 8.65% |
| 2019-Q10/3 |
LoseMGRX / S&P MGRX unavailable / 13.65% |
LoseMGRX / S&P MGRX unavailable / 8.12% |
LoseMGRX / S&P MGRX unavailable / 14.29% |
| 2018-Q40/3 |
LoseMGRX / S&P MGRX unavailable / -13.52% |
LoseMGRX / S&P MGRX unavailable / 9.05% |
LoseMGRX / S&P MGRX unavailable / 18.23% |
| 2018-Q30/3 |
LoseMGRX / S&P MGRX unavailable / 7.71% |
LoseMGRX / S&P MGRX unavailable / 10.21% |
LoseMGRX / S&P MGRX unavailable / 19.06% |
| 2018-Q20/3 |
LoseMGRX / S&P MGRX unavailable / 3.43% |
LoseMGRX / S&P MGRX unavailable / 9.03% |
LoseMGRX / S&P MGRX unavailable / 14.46% |
| 2018-Q10/3 |
LoseMGRX / S&P MGRX unavailable / -0.76% |
LoseMGRX / S&P MGRX unavailable / 7.68% |
LoseMGRX / S&P MGRX unavailable / 12.46% |
| 2017-Q40/3 |
LoseMGRX / S&P MGRX unavailable / 6.64% |
LoseMGRX / S&P MGRX unavailable / 7.03% |
LoseMGRX / S&P MGRX unavailable / 13.82% |
| 2017-Q30/3 |
LoseMGRX / S&P MGRX unavailable / 4.48% |
LoseMGRX / S&P MGRX unavailable / 5.68% |
LoseMGRX / S&P MGRX unavailable / 17.57% |
| 2017-Q20/3 |
LoseMGRX / S&P MGRX unavailable / 3.09% |
LoseMGRX / S&P MGRX unavailable / 4.83% |
LoseMGRX / S&P MGRX unavailable / 17.74% |
| 2017-Q10/3 |
LoseMGRX / S&P MGRX unavailable / 6.07% |
LoseMGRX / S&P MGRX unavailable / 3.67% |
LoseMGRX / S&P MGRX unavailable / 13.32% |
| 2016-Q40/3 |
LoseMGRX / S&P MGRX unavailable / 3.82% |
LoseMGRX / S&P MGRX unavailable / 2.09% |
LoseMGRX / S&P MGRX unavailable / 7.05% |
| 2016-Q30/3 |
LoseMGRX / S&P MGRX unavailable / 3.85% |
LoseMGRX / S&P MGRX unavailable / 0.20% |
LoseMGRX / S&P MGRX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | MGRX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -83.05% | 20.78% |
| Annualized return | -83.05% | 20.78% |
5Y · 2023-03-21 to 2026-08-27
| Metric | MGRX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.33% | 83.14% |
| Annualized return | -63.29% | 12.86% |
10Y · 2023-03-21 to 2026-08-27
| Metric | MGRX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.33% | 319.30% |
| Annualized return | -39.41% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |